Ceftolozane-tazobactam associated with higher clinical cure rates in multidrug-resistant Pseudomonas aeruginosa infections
Comparing Two Different Antibiotics for Treating Tough Pseudomonas Aeruginosa Infections
Researchers compared ceftolozane-tazobactam and ceftazidime-avibactam for treating multidrug-resistant and difficult-to-treat Pseudomonas ae…
Doctors are comparing two powerful antibiotics to see which one works best against hard-to-treat bacterial infections.
Pharmacokinetic and clinical data inform therapeutic selection for difficult to treat Pseudomonas aeruginosa CNS infections
New strategies help treat drug resistant brain infections
This narrative review evaluates the feasibility of various antimicrobial agents, including ceftolozane-tazobactam, ceftazidime-avibactam, az…
Doctors are finding new ways to treat serious brain infections caused by bacteria that have become hard to kill with standard medicine.